Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Completed 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 4Depression 3Anxiety Disorders 3Neoplasm Metastasis 2Hospice 1Hematologic Neoplasms 1

Interventions

Therapeutics 21Psychiatric Rehabilitation 20Surveys and Questionnaires 7Early Intervention, Educational 6Counseling 6Yoga 5Psychosocial Intervention 5Cognitive Behavioral Therapy 5Behavior Therapy 5Mindfulness 4Ketamine 4Exercise 4Escitalopram 4Acupuncture Therapy 4Saline Solution 3Psilocybin 3Mindfulness-Based Stress Reduction 3Mindfulness-Based Cognitive Therapy 3Methods 3Exercise Therapy 3Control Groups 3Citalopram 3Chemotherapy, Adjuvant 3Sugars 2Sertraline 2Palliative Care 2Observation 2Niacin 2Mental Status and Dementia Tests 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Depression × Psilocybin × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Johns Hopkins University

Phase 2 Completed
56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡